🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 18 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/06/1984 | 2,38 | 2,42 | 2,38 | 2,41 | +0,83% | 1,53% | 10.043.194 |
| 15/06/1984 | 2,40 | 2,41 | 2,38 | 2,39 | +0,14% | 1,38% | 5.338.512 |
| 14/06/1984 | 2,38 | 2,39 | 2,36 | 2,39 | +0,56% | 1,53% | 4.738.637 |
| 13/06/1984 | 2,34 | 2,38 | 2,34 | 2,37 | +1,99% | 1,84% | 9.096.221 |
| 12/06/1984 | 2,35 | 2,35 | 2,32 | 2,33 | -0,84% | 1,41% | 4.368.902 |
| 11/06/1984 | 2,37 | 2,37 | 2,34 | 2,35 | -0,98% | 1,12% | 3.067.286 |
| 08/06/1984 | 2,37 | 2,37 | 2,35 | 2,37 | +0,56% | 0,98% | 5.247.965 |
| 07/06/1984 | 2,36 | 2,38 | 2,35 | 2,36 | -0,42% | 1,12% | 2.339.136 |
| 06/06/1984 | 2,33 | 2,37 | 2,33 | 2,37 | +0,85% | 1,42% | 4.429.267 |
| 05/06/1984 | 2,36 | 2,36 | 2,34 | 2,35 | -0,42% | 1,12% | 3.870.893 |
| 04/06/1984 | 2,35 | 2,39 | 2,33 | 2,36 | +0,57% | 2,25% | 9.643.277 |
| 01/06/1984 | 2,29 | 2,34 | 2,29 | 2,34 | +3,51% | 2,17% | 12.869.021 |
| 31/05/1984 | 2,24 | 2,27 | 2,24 | 2,26 | +2,25% | 1,33% | 10.597.795 |
| 30/05/1984 | 2,23 | 2,27 | 2,19 | 2,21 | -2,91% | 3,71% | 16.298.496 |
| 29/05/1984 | 2,29 | 2,31 | 2,27 | 2,28 | -1,43% | 1,59% | 3.701.117 |
| 25/05/1984 | 2,32 | 2,34 | 2,31 | 2,31 | -0,85% | 1,14% | 5.508.288 |
| 24/05/1984 | 2,37 | 2,37 | 2,33 | 2,33 | -1,54% | 1,81% | 11.673.043 |
| 23/05/1984 | 2,38 | 2,38 | 2,35 | 2,37 | +0,14% | 1,25% | 7.236.230 |
| 22/05/1984 | 2,38 | 2,39 | 2,37 | 2,37 | -0,70% | 1,11% | 4.610.362 |
| 21/05/1984 | 2,38 | 2,40 | 2,38 | 2,38 | +0,14% | 0,97% | 3.629.434 |
| 18/05/1984 | 2,42 | 2,43 | 2,35 | 2,38 | -1,78% | 3,56% | 9.801.734 |
| 17/05/1984 | 2,42 | 2,43 | 2,41 | 2,42 | -0,41% | 0,69% | 3.165.379 |
| 16/05/1984 | 2,42 | 2,45 | 2,41 | 2,43 | +0,69% | 1,65% | 7.111.728 |
| 15/05/1984 | 2,41 | 2,44 | 2,41 | 2,42 | +0,27% | 1,10% | 3.633.206 |
| 14/05/1984 | 2,40 | 2,41 | 2,39 | 2,41 | +0,56% | 0,97% | 1.863.763 |
| 11/05/1984 | 2,41 | 2,41 | 2,39 | 2,40 | -0,69% | 1,10% | 2.044.858 |
| 10/05/1984 | 2,39 | 2,42 | 2,39 | 2,41 | +1,11% | 1,53% | 4.406.630 |
| 09/05/1984 | 2,41 | 2,42 | 2,38 | 2,39 | -0,96% | 1,78% | 3.697.344 |
| 08/05/1984 | 2,38 | 2,42 | 2,37 | 2,41 | +1,25% | 2,09% | 4.542.451 |
| 07/05/1984 | 2,38 | 2,39 | 2,37 | 2,38 | -0,28% | 0,84% | 3.591.706 |